Department of Neuroscience, Croatian Institute for Brain Research, University of Zagreb Medical School, Zagreb, Croatia.
Department of Molecular Medicine, Institute Ruđer Bošković, Zagreb, Croatia.
J Alzheimers Dis. 2020;75(3):1029-1047. doi: 10.3233/JAD-200056.
Neuroinflammation plays an important role in Alzheimer's disease (AD). During this process, activated microglia release pro-inflammatory cytokines such as interleukin (IL)-1α, IL-1β, IL-6, and tumor necrosis factor α (TNFα) that participate in neuron damage, but also anti-inflammatory cytokines (such as IL-10), which maintain homeostasis of immune response. Previous studies showed the association of IL-1α -889C/T (rs1800587), IL-1β-1473G/C (rs1143623), IL-6 -174C/G (rs1800795), IL-10 -1082G/A (rs1800896), and TNFα -308A/G (rs1800629) polymorphisms with AD.
We aimed to investigate whether people with certain IL-1α, IL-1β, IL-6, IL-10, and TNFα genotypes in these polymorphisms are more prone to develop AD-related pathology, reflected by pathological levels of cerebrospinal fluid (CSF) AD biomarkers including amyloid-β1-42, total tau (t-tau), tau phosphorylated at Thr 181 (p-tau181), Ser 199 (p-tau199), and Thr 231 (p-tau231), and visinin-like protein 1 (VILIP-1).
The study included 115 AD patients, 53 patients with mild cognitive impairment, and 11 healthy controls. The polymorphisms were determined using real-time polymerase chain reaction. Levels of CSF biomarkers were determined by enzyme-linked immunosorbent assay.
A significant increase in p-tau CSF levels was found in patients with the AA IL-10 -1082G/A and GG TNFα -308A/G genotypes, and in carriers of a G allele in IL-1β -1473C/G and IL-6 -174C/G polymorphisms. t-tau levels were increased in carriers of a G allele in IL-1β -1473C/G polymorphism. An increase in VILIP-1 levels was observed in patients with CG and GG IL-1β -1473C/G, GC IL-6 -174C/G, and GG TNFα -308A/G genotype.
These results suggest that persons carrying certain genotypes in IL10 (-1082G/A), IL1β (1473C/G), IL6 (-174C/G), and TNFIα (-308A/G) could be more vulnerable to development of neuroinflammation, and consequently of AD.
神经炎症在阿尔茨海默病(AD)中起着重要作用。在此过程中,活化的小胶质细胞释放促炎细胞因子,如白细胞介素(IL)-1α、IL-1β、IL-6 和肿瘤坏死因子 α(TNFα),这些细胞因子参与神经元损伤,但也有抗炎细胞因子(如 IL-10),它们维持免疫反应的稳态。先前的研究表明,IL-1α-889C/T(rs1800587)、IL-1β-1473G/C(rs1143623)、IL-6-174C/G(rs1800795)、IL-10-1082G/A(rs1800896)和 TNFα-308A/G(rs1800629)多态性与 AD 有关。
我们旨在研究这些多态性中特定的 IL-1α、IL-1β、IL-6、IL-10 和 TNFα 基因型的个体是否更容易发展为 AD 相关的病理,这反映在脑脊液(CSF)AD 生物标志物的病理水平上,包括淀粉样蛋白-β1-42、总 tau(t-tau)、tau 磷酸化 Thr181(p-tau181)、Ser199(p-tau199)和 Thr231(p-tau231)以及 visinin-like 蛋白 1(VILIP-1)。
该研究纳入了 115 名 AD 患者、53 名轻度认知障碍患者和 11 名健康对照者。采用实时聚合酶链反应法确定多态性。采用酶联免疫吸附试验测定 CSF 生物标志物水平。
AA 型 IL-10-1082G/A 和 GG 型 TNFα-308A/G 基因型患者的 p-tau CSF 水平显著升高,IL-1β-1473C/G 和 IL-6-174C/G 多态性中携带 G 等位基因的患者 t-tau 水平升高。IL-1β-1473C/G 多态性中携带 G 等位基因的患者 VILIP-1 水平升高。IL-1β-1473C/G 中 CG 和 GG 型、IL-6-174C/G 中 GC 型和 TNFα-308A/G 中 GG 型患者 VILIP-1 水平升高。
这些结果表明,携带特定基因型的个体在 IL10(-1082G/A)、IL1β(1473C/G)、IL6(-174C/G)和 TNFIα(-308A/G)中可能更容易发生神经炎症,进而发展为 AD。